Intravitreal Fasudil Combined with Bevacizumab for Treatment of Refractory Diabetic Macular Edema; a Pilot Study

PURPOSE: To evaluate the effect of intravitreal injection of a Rho-associated protein kinase (ROCK) inhibitor (Fasudil, Asahi Kasei Pharma Corporation, Tokyo, Japan) combined with intravitreal bevacizumab (IVB) on refractory diabetic macular edema (DME). METHODS: This prospective, interventional cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Nourinia, Ramin, Ahmadieh, Hamid, Shahheidari, Mohammad-Hassan, Zandi, Souska, Nakao, Shintaro, Hafezi-Moghadam, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ophthalmic Research Center 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957040/
https://www.ncbi.nlm.nih.gov/pubmed/24653821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957040/
https://www.ncbi.nlm.nih.gov/pubmed/24653821

Ejemplares similares